GunturuK.; Abu-KhalafM.; SaifM. Hepatic Failure and Hepatorenal Syndrome Secondary to Erlotinib: A Possible Etiology of Complications in a Patient with Pancreatic Cancer. JOP. Journal of the Pancreas, v. 11, n. 5, p. 484-485, 6 set. 2010.